BriaCell Therapeutics Corp. (BCTX, BCTXL, BCTXZ) (CIK 0001610820) (BCTX)
Activity window: Nov. 12, 2025 to Nov. 11, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Jan. 8, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Jan. 8, 2026 | CORRESP | Neutral/Informational | Low | BriaCell Therapeutics Corp. has submitted a correspondence to the SEC regarding its Registration Statement on Form S-1. The company is withdrawing its previous request for an acce… | Read Filing EDGAR |
| Jan. 8, 2026 | CORRESP | Neutral/Informational | Moderate | BriaCell Therapeutics Corp. has submitted a correspondence to the SEC regarding its Registration Statement on Form S-1. The company, through its placement agent ThinkEquity LLC, h… | Read Filing EDGAR |
| Jan. 6, 2026 | CORRESP | Neutral/Informational | Moderate | BriaCell Therapeutics Corp. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1 to January 8, 2026. This request indica… | Read Filing EDGAR |
| Jan. 6, 2026 | CORRESP | Neutral/Informational | Moderate | BriaCell Therapeutics Corp. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1 to January 8, 2026. ThinkEquity LLC, ac… | Read Filing EDGAR |